386 filings
Page 13 of 20
8-K
ale91eejrtw9ycw
30 Apr 10
Adventrx Reports First Quarter Financial Results
12:00am
8-K
avtju9b62hx6n
27 Apr 10
Adventrx to Resubmit ANX-530 Nda In the Fourth Quarter of 2010
12:00am
8-K
po8 b7rqyg2i0m
26 Apr 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
0t6o mkh5syved8p
16 Apr 10
Results of Operations and Financial Condition
12:00am
8-K
jm2e2 v6tu35fi
16 Mar 10
Adventrx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
12:00am
8-K
m181go 8b
1 Mar 10
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
12:00am
8-K
k8vbx9f13ikytlla32a2
4 Feb 10
Adventrx Announces Management Promotions
12:00am
8-K
ee793wrgc4m6dp jg
4 Feb 10
Departure of Directors or Certain Officers
12:00am
8-K
cyp1mrs8
3 Feb 10
Adventrx Appoints Icahn Representative to Board of Directors
12:00am
8-K
aqrl02p
26 Jan 10
Departure of Directors or Certain Officers
12:00am
8-K
t25mt5lusf
4 Jan 10
Adventrx Pharmaceuticals Announces Financing
12:00am
8-K
ik71hektqkzkuf 0xs
4 Jan 10
Other Events
12:00am
8-K
6ra1mv blp
24 Dec 09
Entry into a Material Definitive Agreement
12:00am
8-K
9nj8qofjr1
10 Nov 09
Adventrx Pharmaceuticals Reports Third Quarter Financial Results
12:00am
8-K
5ccrsu
19 Oct 09
Departure of Directors or Certain Officers
12:00am
8-K
yrrutg gr731acw1wc5
13 Oct 09
Adventrx Pharmaceuticals Announces Financing
12:00am
8-K
5mbs52vx92 ok7b0
1 Sep 09
Entry into a Material Definitive Agreement
12:00am
8-K
fey9i8zus3nn4ruxbt
28 Aug 09
Entry into a Material Definitive Agreement
12:00am
8-K
3vq9x20 37
20 Aug 09
Entry into a Material Definitive Agreement
12:00am
8-K
lrvleay0yddn9
12 Aug 09
Adventrx Pharmaceuticals Reports Second Quarter Financial Results
12:00am